DocMeetings

We are excited to be hosting Tribe Public's Next Webinar Presentation and Q&A Event which will be held Thursday, August 25 (8 am PT/ 11 am ET). Our events are approximately 30 minutes in duration.

Steven Quay, MD, PhD, CEO & Founder & Kyle Guse CFO of Atossa Therapeutics (NASDAQ: ATOS) will deliver a presentation titled "The Important Role For Inhalation Therapy In Oncology." Atossa management will also speak to new opportunities for its inhalation therapy, AT-H201, to potentially treat lung injury caused by cancer treatment. They will be also be available for a 5-10 minute Q&A session at the end of the presentation. Send Questions to email: research@tribepublic.com.

Dr. Quay is an author, entrepreneur, and accomplished physician-scientist that has founded six startups invented seven FDA-approved pharmaceuticals and holds 87 US patents. Over 80 million people have benefited from the medicines he invented. He received his M.D., M.A., and Ph.D. from The University of Michigan. He was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana and a resident at the Harvard-Massachusetts General Hospital. He was on the faculty of Stanford University School of Medicine for almost a decade.

Atossa Therapeutics (NASDAQ: ATOS), is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19.
By registering for this event you are agreeing to join Tribe Public (www.tribepublic.com) & to receive future FREE invitations. Disclaimer: https://tribepublic.com/disclaimers.